AstraZeneca taps Ericsson exec as chairman; Merck settles investor suit over Vytorin trial;

@FiercePharma: Greece austerity deal includes mandated generics, drug-spending limits--Reuters. Article | Follow @FiercePharma

> After a long search, AstraZeneca ($AZN) has named a new chairman to replace Louis Schweitzer: Leif Johansson, chairman of Swedish telecom Ericsson. News

> Merck ($MRK) has settled a shareholder suit that had claimed it delayed negative trial results affecting its Vytorin cholesterol pill. Story

> AstraZeneca won FDA approval for its new version of FluMist, dubbed FluMist Quadrivalent, an influenza vaccine that fights four strains of the virus. Report

> Bayer got the FDA's nod for a lower-dose version of its hormone therapy Angeliq, as a treatment for menopausal symptoms. More

> Sanofi ($SNY) and Japan's Astellas Pharma agreed to dissolve their joint venture, Sanofi-aventis Yamanouchi, formed to market the heart drug Milrila, in favor of a licensing agreement on the product. News

> A U.S. judge has denied Cardinal Health's request for an injunction, allowing the Drug Enforcement Administration to suspend controlled-substance shipments from the company's Lakeland, FL, distribution center. Report

Biotech News

@FierceBiotech: AstraZeneca's FluMist Quadrivalent #vaccine to hit U.S. market. Story | Follow @FierceBiotech

 @JohnCFierce: Smart: Keep Kelly Martin as CEO at Elan until bapineuzumab data comes in. New guy can pick up the pieces; or Martin ends up unlikely hero. | Follow @JohnCFierce

@RyanMFierce: Eli Lilly has trotted out a $10M program with academic partners that has long odds of bringing the company any new drugs. More | Follow @RyanMFierce

@MarkHFierce: Math + genetics + health data helps Utah doctors customize blood thinner dosing. Surprisingly practical. Story | Follow @MarkHFierce

> Elan CEO puts retirement party on hold as Alzheimer's PhIII looms. More

> GSK and Daiichi create new vaccine joint development venture in Japan. Story

> Pfizer, BMS face a delay on FDA's megablockbuster decision on apixaban. News

Vaccines News

> Universal vaccine could cut flu across the whole community. Report

> Inactivated polio vaccine reaches Nigeria. More

> Bacteria may lead to HIV vaccine. Article

> Getting under the skin of vaccines. Story

> Cell-based pancreatic cancer vaccine increases survival. News

Manufacturing News

> IT issues at Biochem lab raise data integrity concerns. Article

> Industry faces having to fund drug-disposal program. Story

> FDA puts burning questions to Fukuda Denshi about device. More

> Abbott banks on boomers with $270M nutrition facility. Item

CRO News

> Newsummit Biopharma's $80M IPO reflects CRO surge in China. More

> Icon snatches up drug pricing guru PriceSpective. Article

> Quintiles partners with Russians on new drug development ventures. News

> Feds say contract testing lab's protocols damaged data integrity. Story

And Finally... Daily doses of a Parkinson's disease drug, amantadine hydrochloride, improved function in people with severe brain injuries, researchers said. Article